The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma

被引:1
|
作者
Ning, Zhong-Hua [1 ,2 ]
Zhao, Wei [3 ]
Li, Xiao-Dong [1 ]
Chen, Lu-Jun [1 ]
Xu, Bin [1 ]
Gu, Wen-Dong [2 ]
Shao, Ying-Jie [2 ]
Xu, Yun [1 ]
Huang, Jin [2 ]
Pei, Hong-Lei [2 ]
Jiang, Jing-Ting [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou 213003, Peoples R China
[2] Soochow Univ, Affiliated Hosp 3, Dept Radiat Oncol, Changzhou 213003, Peoples R China
[3] Soochow Univ, Affiliated Hosp 3, Dept Pathol, Changzhou 213003, Peoples R China
基金
中国国家自然科学基金;
关键词
Biomarkers; perineural invasion; prognosis; esophageal squamous cell carcinoma; postoperative radiotherapy; PROSTATE-CANCER; NEURAL INVASION; CURATIVE RESECTION; PANCREATIC-CANCER; RADIATION-THERAPY; SURVIVAL; ADJUVANT; CHEMORADIOTHERAPY; NEOADJUVANT; STROMA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Prognosis of locally advanced esophageal squamous cell carcinoma (ESCC) remains dismal even after curative resection and adjuvant radiotherapy. New biomarkers for predicting prognosis and treatment outcomes are needed for improved treatment stratification of patients with locally advanced ESCC. The prognostic and treatment predictive significance of perineural invasion (PNI) in the locally advanced ESCC remains unclear. This study aimed to examine the effect of PNI on the outcomes of locally advanced ESCC patients after curative resection with or without postoperative radiotherapy (PORT). Patients and methods: We retrospectively reviewed 262 consecutive locally advanced ESCC patients who underwent curative resection. Tumors sections were re-evaluated for PNI by an independent pathologist blinded to the patients' outcomes. Overall survival (OS) and disease-free survival (DFS) were determined using the Kaplan-Meier method; univariate log-rank test and multivariate Cox proportional hazard model were used to evaluate the prognostic value of PNI. Results: Finally, 243 patients were analyzed and enrolled into this study, of which 132 received PORT. PNI was identified in 22.2% (54/243) of the pathologic sections. The 5-year DFS was favorable for PNI-negative patients versus PNI-positive patients (21.3% vs. 36.7%, respectively; P = 0.005). The 5-year OS was 40.3% for PNI-negative patients versus 21.7% for PNI-positive patients (P < 0.001). On multivariate analysis, PNI was an independent prognostic factor. In a subset analysis for patients received PORT, PNI was evaluated as a prognostic predictor as well (P < 0.05). In contrast to patients without PORT, PORT couldn't improve the disease recurrence and survival in locally advanced ESCC patients with PNI-positive (P > 0.05). Conclusions: PNI could serve as an independent prognostic factor and prognosticate treatment outcomes in locally advanced ESCC patients. The PNI status should be considered when stratifying high-risk locally advanced ESCC patients for adjuvant radiotherapy. Future prospective study is warranted to confirm our results.
引用
收藏
页码:6881 / 6890
页数:10
相关论文
共 50 条
  • [1] A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma
    Zhang, Zhaoyue
    Xu, Liping
    Di, Xiaoke
    Zhang, Chi
    Ge, Xiaolin
    Sun, Xinchen
    ANNALS OF PALLIATIVE MEDICINE, 2019, 8 (05) : 708 - 716
  • [3] Survival outcomes in locally advanced cutaneous squamous cell carcinoma presenting with clinical perineural invasion alone
    Hazim, Antonious Z.
    Reed, Clay T.
    Price, Katharine A.
    Foote, Robert L.
    Ma, Daniel J.
    Neben-Wittich, Michelle
    DeLone, David R.
    Jenkins, Sarah M.
    Smith, Carin Y.
    Chintakuntlawar, Ashish V.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (07): : 1995 - 2001
  • [4] The prognostic effect of perineural invasion in esophageal squamous cell carcinoma
    Jie-Wei Chen
    Jing-Dun Xie
    Yi-Hong Ling
    Peng Li
    Shu-Mei Yan
    Shao-Yan Xi
    Rong-Zhen Luo
    Jing-Ping Yun
    Dan Xie
    Mu-Yan Cai
    BMC Cancer, 14
  • [5] The prognostic effect of perineural invasion in esophageal squamous cell carcinoma
    Chen, Jie-Wei
    Xie, Jing-Dun
    Ling, Yi-Hong
    Li, Peng
    Yan, Shu-Mei
    Xi, Shao-Yan
    Luo, Rong-Zhen
    Yun, Jing-Ping
    Xie, Dan
    Cai, Mu-Yan
    BMC CANCER, 2014, 14
  • [6] A retrospective study of postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Yeh, Hui-Ling
    Hsu, Chung-Ping
    Lin, Jin-Ching
    Jan, Jian-Sheng
    Lin, Jai-Fu
    Chang, Chen-Fa
    FORMOSAN JOURNAL OF SURGERY, 2012, 45 (06) : 172 - 177
  • [7] The expression of PDGF-BB predicts curative effect in locally advanced esophageal squamous cell carcinoma treated by radiotherapy
    Er, Puchun
    Qian, Dong
    Zhang, Wencheng
    Zhang, Baozhong
    Wei, Hui
    Zhang, Tian
    Chen, Xi
    Wang, Yuwen
    Zhao, Jingjing
    Wang, Qi
    Pang, Qingsong
    Wang, Ping
    AGING-US, 2020, 12 (08): : 6586 - 6599
  • [8] Adjunctive Radiotherapy in the Treatment of Cutaneous Squamous Cell Carcinoma With Perineural Invasion
    Waxweiler, Weston
    Sigmon, Justin R.
    Sheehan, Daniel J.
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (01) : 104 - 105
  • [9] Delayed postoperative radiotherapy might improve the long-term prognosis of locally advanced esophageal squamous cell carcinoma
    Lin, Ming-qiang
    Li, Jin-luan
    Zhang, Zong-kai
    Chen, Xiao-hui
    Ma, Jia-yu
    Dai, Ya-qing
    Huang, Shu-yun
    Hu, Yi-bin
    Li, Jian-cheng
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [10] Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma
    Zhang, Wencheng
    Yan, Cihui
    Gao, Xuan
    Li, Xiaoxia
    Cao, Fuliang
    Zhao, Gang
    Zhao, Jingjing
    Er, Puchun
    Zhang, Tian
    Chen, Xi
    Wang, Yuwen
    Jiang, Yao
    Wang, Quanren
    Zhang, Baozhong
    Qian, Dong
    Wang, Jun
    Zhou, Dejun
    Ren, Xiubao
    Yu, Zhentao
    Zhao, Lujun
    Yuan, Zhiyong
    Wang, Ping
    Pang, Qingsong
    ONCOLOGIST, 2021, 26 (07): : E1110 - E1124